Stericycle Inc. (SRCL) Stake Held by Blue Fin Capital Inc.
Blue Fin Capital Inc. continued to hold its stake in Stericycle Inc. (NASDAQ:SRCL) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,365 shares of the company’s stock at the end of the second quarter. Blue Fin Capital Inc.’s holdings in Stericycle were worth $246,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of SRCL. Prudential Financial Inc. raised its stake in Stericycle by 3.0% in the first quarter. Prudential Financial Inc. now owns 109,323 shares of the company’s stock worth $13,795,000 after buying an additional 3,225 shares during the period. BlackRock Fund Advisors raised its stake in Stericycle by 6.4% in the first quarter. BlackRock Fund Advisors now owns 1,707,528 shares of the company’s stock worth $215,473,000 after buying an additional 103,024 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in Stericycle by 0.8% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,289,722 shares of the company’s stock worth $288,940,000 after buying an additional 19,063 shares during the period. M&T Bank Corp raised its stake in Stericycle by 13.1% in the first quarter. M&T Bank Corp now owns 14,701 shares of the company’s stock worth $1,854,000 after buying an additional 1,700 shares during the period. Finally, Aviva PLC raised its stake in Stericycle by 34.3% in the first quarter. Aviva PLC now owns 118,360 shares of the company’s stock worth $14,936,000 after buying an additional 30,233 shares during the period. 92.72% of the stock is owned by institutional investors and hedge funds.
Shares of Stericycle Inc. (NASDAQ:SRCL) traded up 1.43% during midday trading on Friday, hitting $75.44. 673,994 shares of the stock traded hands. The firm’s 50 day moving average price is $80.45 and its 200 day moving average price is $98.03. The company has a market capitalization of $6.42 billion, a PE ratio of 26.55 and a beta of 0.20. Stericycle Inc. has a 12-month low of $72.89 and a 12-month high of $151.57.
Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.18. The firm had revenue of $891.60 million for the quarter, compared to analysts’ expectations of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The business’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.14 EPS. Analysts expect that Stericycle Inc. will post $4.67 EPS for the current year.
SRCL has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Tuesday, June 28th. Jefferies Group restated a “buy” rating and issued a $140.00 price objective on shares of Stericycle in a report on Monday, July 18th. Imperial Capital downgraded Stericycle from an “in-line” rating to an “underperform” rating and dropped their price objective for the stock from $100.00 to $93.50 in a report on Friday, July 29th. Wellington Shields downgraded Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Finally, Macquarie started coverage on Stericycle in a report on Thursday, August 25th. They issued a “neutral” rating and a $96.00 price objective on the stock. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $103.54.
In other Stericycle news, EVP John P. Schetz sold 1,398 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the sale, the executive vice president now owns 1,088 shares in the company, valued at approximately $89,052.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Rodney F. Dammeyer sold 10,188 shares of the business’s stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $85.50, for a total value of $871,074.00. Following the completion of the sale, the director now owns 10,188 shares in the company, valued at approximately $871,074. The disclosure for this sale can be found here. 3.30% of the stock is owned by company insiders.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.